ATE366819T1 - Genetische immunisierung gegen zervixkarzinom - Google Patents
Genetische immunisierung gegen zervixkarzinomInfo
- Publication number
- ATE366819T1 ATE366819T1 AT01979106T AT01979106T ATE366819T1 AT E366819 T1 ATE366819 T1 AT E366819T1 AT 01979106 T AT01979106 T AT 01979106T AT 01979106 T AT01979106 T AT 01979106T AT E366819 T1 ATE366819 T1 AT E366819T1
- Authority
- AT
- Austria
- Prior art keywords
- cervical carcinoma
- immunization against
- genetic immunization
- medicament
- against cervical
- Prior art date
Links
- 208000019065 cervical carcinoma Diseases 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 2
- 241000701806 Human papillomavirus Species 0.000 abstract 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 2
- 201000010881 cervical cancer Diseases 0.000 abstract 2
- 241000710929 Alphavirus Species 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/10—Vectors comprising a special translation-regulating system regulates levels of translation
- C12N2840/105—Vectors comprising a special translation-regulating system regulates levels of translation enhancing translation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/60—Vectors comprising a special translation-regulating system from viruses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20000203472 EP1195438A1 (de) | 2000-10-06 | 2000-10-06 | Genetische Immunisierung gegen Zervixkarzinom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE366819T1 true ATE366819T1 (de) | 2007-08-15 |
Family
ID=8172111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01979106T ATE366819T1 (de) | 2000-10-06 | 2001-10-08 | Genetische immunisierung gegen zervixkarzinom |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7198792B2 (de) |
| EP (3) | EP1195438A1 (de) |
| AT (1) | ATE366819T1 (de) |
| AU (1) | AU2002211095A1 (de) |
| CA (1) | CA2424700C (de) |
| DE (1) | DE60129358T2 (de) |
| ES (1) | ES2290177T3 (de) |
| WO (1) | WO2002029074A2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8791237B2 (en) * | 1994-11-08 | 2014-07-29 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of non-hodgkins lymphoma |
| US8114414B2 (en) * | 1994-11-08 | 2012-02-14 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical cancer |
| EP1195438A1 (de) * | 2000-10-06 | 2002-04-10 | Rijksuniversiteit te Groningen | Genetische Immunisierung gegen Zervixkarzinom |
| US8771702B2 (en) * | 2001-03-26 | 2014-07-08 | The Trustees Of The University Of Pennsylvania | Non-hemolytic LLO fusion proteins and methods of utilizing same |
| CA3057039C (en) * | 2006-07-28 | 2023-02-28 | The Trustees Of The University Of Pennsylvania | Hiv consensus envelope sequences and methods for using same |
| EP3167875A1 (de) | 2009-05-27 | 2017-05-17 | Alkermes Pharma Ireland Limited | Reduktion von flockenartiger aggregation in nanoteilchenförmigen meloxicamzusammensetzungen |
| EP2335730A1 (de) * | 2009-12-18 | 2011-06-22 | Deutsches Krebsforschungszentrum | Fusionspolypeptide und ihre Verwendung zur Vorbeugung und Behandlung von Krebs |
| US20170074881A1 (en) * | 2014-05-07 | 2017-03-16 | Vincenzo MACCALLINI | Method for detecting carcinogenesis in the uterine cervix |
| JP7250520B2 (ja) | 2016-04-13 | 2023-04-03 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 組換えアルテリウイルスレプリコン系およびその使用 |
| WO2018060288A1 (en) | 2016-09-29 | 2018-04-05 | Glaxosmithkline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| CA3045650A1 (en) * | 2016-12-05 | 2018-06-14 | Janssen Pharmaceuticals, Inc. | Compositions and methods for enhancing gene expression |
| EP3461497A1 (de) * | 2017-09-27 | 2019-04-03 | GlaxoSmithKline Biologicals S.A. | Virale antigene |
| CN108060135A (zh) * | 2017-12-26 | 2018-05-22 | 东莞赛尔生物科技有限公司 | 一种高效表达p53抑癌蛋白的t细胞、制备方法及应用 |
| NL2022538B1 (en) | 2019-02-08 | 2020-08-19 | Academisch Ziekenhuis Groningen | Methods for providing purified viral particles of Semliki Forest Virus (SFV), preparations obtainable thereby, and uses thereof. |
| CN111978375B (zh) * | 2020-08-28 | 2022-10-04 | 深圳市乐土生物医药有限公司 | 具有细胞毒性t细胞诱导能力的蛋白质或多肽 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0814154T3 (da) * | 1993-09-15 | 2009-08-31 | Novartis Vaccines & Diagnostic | Rekombinante alfavirusvektorer |
| US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| US5842723A (en) * | 1996-11-25 | 1998-12-01 | Burex Automotive America, Inc. | Flexible connection arrangement for connecting a pipe of an exhaust system to an engine, especially in a motor vehicle |
| CA2311395C (en) * | 1997-11-28 | 2006-11-28 | Replikun Biotech Pty Ltd | Flavivirus expression and delivery system |
| EP1195438A1 (de) | 2000-10-06 | 2002-04-10 | Rijksuniversiteit te Groningen | Genetische Immunisierung gegen Zervixkarzinom |
-
2000
- 2000-10-06 EP EP20000203472 patent/EP1195438A1/de not_active Withdrawn
-
2001
- 2001-10-08 WO PCT/NL2001/000740 patent/WO2002029074A2/en not_active Ceased
- 2001-10-08 EP EP20070107752 patent/EP1865066A3/de not_active Withdrawn
- 2001-10-08 AU AU2002211095A patent/AU2002211095A1/en not_active Abandoned
- 2001-10-08 ES ES01979106T patent/ES2290177T3/es not_active Expired - Lifetime
- 2001-10-08 AT AT01979106T patent/ATE366819T1/de not_active IP Right Cessation
- 2001-10-08 CA CA 2424700 patent/CA2424700C/en not_active Expired - Fee Related
- 2001-10-08 DE DE2001629358 patent/DE60129358T2/de not_active Expired - Lifetime
- 2001-10-08 EP EP01979106A patent/EP1370666B1/de not_active Expired - Lifetime
-
2003
- 2003-04-04 US US10/406,818 patent/US7198792B2/en not_active Expired - Lifetime
-
2007
- 2007-03-07 US US11/714,960 patent/US20070166328A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20070166328A1 (en) | 2007-07-19 |
| DE60129358T2 (de) | 2008-05-08 |
| EP1865066A2 (de) | 2007-12-12 |
| WO2002029074A3 (en) | 2003-10-16 |
| DE60129358D1 (de) | 2007-08-23 |
| EP1865066A3 (de) | 2007-12-19 |
| EP1370666A2 (de) | 2003-12-17 |
| CA2424700A1 (en) | 2002-04-11 |
| CA2424700C (en) | 2010-06-01 |
| EP1195438A1 (de) | 2002-04-10 |
| WO2002029074A2 (en) | 2002-04-11 |
| ES2290177T3 (es) | 2008-02-16 |
| US7198792B2 (en) | 2007-04-03 |
| EP1370666B1 (de) | 2007-07-11 |
| AU2002211095A1 (en) | 2002-04-15 |
| US20040005711A1 (en) | 2004-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE366819T1 (de) | Genetische immunisierung gegen zervixkarzinom | |
| NO20091761L (no) | Viruskapsomervaksine, fremgangsmate for fremstilling samt anvendelse derav | |
| HUP9802819A2 (hu) | Hősokkfehérje-alapú oltóanyagok és immunterápiák | |
| EP1246644A4 (de) | Induzierung zellulärer immunantworten auf humanen papillomavirus unter verwendung von peptiden und nukleinsäure-zusammensetzungen | |
| HUP0402259A2 (hu) | Vakcinák | |
| ATE270707T1 (de) | Entepneumovirus und entsprechendes impfstoff | |
| PT1409692E (pt) | Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina | |
| DK1531843T3 (da) | Fremgangsmåde til behandling af cervixcancer | |
| HUP9801266A2 (hu) | Multimer, rekombináns ureázvakcina | |
| WO2003078640A3 (en) | Recombinant drug-sensitive vaccinia virus as smallpox vaccine | |
| HUP0300054A1 (hu) | Daganatspecifikus állati fehérjék | |
| MXPA03000061A (es) | Manipulacion de virus de arn encadenados negativos mediante redisposicion de sus genes y usos de los mismos. | |
| EP1159967A4 (de) | Tumorimpfstoff | |
| DE69732029D1 (de) | Dna enthaltende impfstoffen | |
| HUP9902150A2 (hu) | Rekombináns adenovírus vektorok humán tumor génterápiára | |
| CY1107560T1 (el) | Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο | |
| ATE283066T1 (de) | Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp) | |
| MXPA03008832A (es) | Vacunas contra leishmania. | |
| DK56389D0 (da) | Forhindring og behandling af retroviralt frembragte sygdomme | |
| DE60140950D1 (de) | Neuer gentherapeutischer wirkstoff zur behandlung g | |
| WO2002072013A8 (en) | Method of treating malignancies through induction of blood immune responses | |
| WO2005097179A3 (fr) | Antigene tat stabilise et ses applications pour la vaccination anti-vih. | |
| WO2002070004A3 (en) | Papillomavirus vaccines | |
| FR2796282B1 (fr) | Vaccin inactive contre la calicivirose feline | |
| DK1339737T3 (da) | Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |